Organ Recovery Systems’ LifePort® Liver Transporter Preserves First Livers for Transplant as Part of the PILOT™ Continued Access Study


Hitesh

Organ Recovery Systems (ORS) is commemorating the first liver transplants performed at Northwestern Memorial Hospital in Chicago, Illinois, and Rutgers Medical School in New Jersey using the LifePort Liver Transporter (LLT) and Vasosol®. LLT reduces organ deterioration during preservation using oxygenated hypothermic machine perfusion (HMP), which improves patient outcomes and […]

GE Board of Directors Approves Separation of GE HealthCare


Hitesh

General Electric Company announced today that its Board of Directors has approved the previously announced spin-off of its healthcare business, GE Healthcare Holding LLC (“GE HealthCare”). Prior to such spin-off, GE HealthCare is expected to be converted into a corporation and renamed GE HealthCare Technologies Inc. The company is expected […]

Xtalpi And CK Life Sciences To Collaborate In AI-empowered Tumour Vaccine Research And Development, Opening A New Paradigm For Scientific Innovation


Hitesh

Yesterday, XtalPi made a strategic partnership announcement with CK Life Sciences, a part of the CK Hutchison Group. To enhance the discovery and design capabilities of tumour vaccines and speed up the creation of more vaccine kinds, XtalPi and CK Life Sciences will combine their respective skills to establish a […]

FDA Approves First Gene Therapy to Treat Adults with Hemophilia B


Hitesh

Hemgenix (etranacogene dezaparvovec), an adeno-associated virus vector-based gene therapy, has been approved by the U.S. Food and Drug Administration for the treatment of adults with Haemophilia B (congenital factor IX deficiency) who are currently receiving Factor IX prophylaxis therapy, have experienced recent or past life-threatening hemorrhage, or have had recurrent, […]

Jazz Pharmaceuticals Announces U.S. FDA Approval of Monday/Wednesday/Friday Intramuscular Dosing Schedule for Rylaze®


Hitesh

Jazz Pharmaceuticals Announces U.S. FDA Approval For Intramuscular Dosing Schedule for Rylaze Rylaze dosing option provides sustained asparaginase activity throughout the course of treatment for adult and pediatric patients with acute lymphoblastic leukemia or lymphoblastic lymphoma Jazz Pharmaceuticals plc announced today that in the United States the Food and Drug […]